Literature DB >> 12684321

Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge.

Joaquín Sastre1, Mar Fernández-Nieto, Ana Novalbos, Manuel De Las Heras, Javier Cuesta, Santiago Quirce.   

Abstract

BACKGROUND: Specific and nonspecific bronchial responsiveness may decline or disappear after cessation of exposure in the workplace in patients with occupational asthma, leading to false-negative specific inhalation challenge (SIC) results.
METHODS: Twenty-two patients with suspected diisocyanate-induced asthma were studied. SIC with diisocyanates (toluene diisocyanate [TDI] or hexamethylene diisocyanate [HDI]) was carried out in a 7-m(3) dynamic chamber up to a maximum concentration of 19 parts per billion for 120 min. Methacholine inhalation challenges were performed before and 24 h after SIC with TDI or HDI. Patients who did not show an asthmatic reaction after SIC but had a greater than twofold reduction in provocative concentration of methacholine causing a 20% fall in FEV(1) (PC(20)) after the first isocyanate challenge underwent a second isocyanate SIC 2 days later.
RESULTS: The first SIC with isocyanates elicited an asthmatic reaction in 13 patients (59%). In five patients who did not show an asthmatic reaction after the first SIC, PC(20) exhibited more than a twofold reduction. In three of the five patients, a second SIC with isocyanates elicited an immediate positive asthmatic reaction. Therefore, 3 of 16 patients (19%) were ultimately shown to have bronchial responsiveness to isocyanate; occupational asthma was demonstrated due to post-SIC monitoring of bronchial hyperresponsiveness to methacholine.
CONCLUSION: PC(20) should be systematically assessed before and after SIC with isocyanates in the absence of significant changes in FEV(1) during SIC to avoid false-negative results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684321     DOI: 10.1378/chest.123.4.1276

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Michael L Kashon; Victor J Johnson; Zana L Lummus; Kara Fluharty; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Immunotoxicol       Date:  2015-09-04       Impact factor: 3.000

Review 2.  Occupational asthma.

Authors:  Nicholas J Kenyon; Brian M Morrissey; Michael Schivo; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

3.  Non-invasive tools beyond lung function before and after specific inhalation challenges for diagnosing occupational asthma.

Authors:  Julia Engel; Vera van Kampen; Vitali Gering; Olaf Hagemeyer; Thomas Brüning; Monika Raulf; Rolf Merget
Journal:  Int Arch Occup Environ Health       Date:  2019-05-29       Impact factor: 3.015

4.  Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Grace E Kissling; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori R Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  Toxicol Sci       Date:  2012-05-17       Impact factor: 4.849

5.  CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population.

Authors:  David I Bernstein; Michael Kashon; Zana L Lummus; Victor J Johnson; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; Berran Yucesoy
Journal:  Toxicol Sci       Date:  2012-09-13       Impact factor: 4.849

6.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

7.  Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma.

Authors:  Bin Ouyang; David I Bernstein; Zana L Lummus; Jun Ying; Louis-Philippe Boulet; André Cartier; Denyse Gautrin; Shuk-Mei Ho
Journal:  Toxicol Sci       Date:  2013-03-27       Impact factor: 4.849

8.  Distinctive bronchial inflammation status in athletes: basophils, a new player.

Authors:  Beatriz Sastre; Mar Fernández-Nieto; María Jesús Rodríguez-Nieto; Erica Aguado; Joaquín Sastre; Victoria del Pozo
Journal:  Eur J Appl Physiol       Date:  2012-08-24       Impact factor: 3.078

9.  N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma.

Authors:  Berran Yucesoy; Grace E Kissling; Victor J Johnson; Zana L Lummus; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Occup Environ Med       Date:  2015-12       Impact factor: 2.162

10.  Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Michael L Kashon; Marepalli Rao; Hansen Bannerman-Thompson; Bonnie Frye; Wei Wang; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Dori R Germolec; Michael I Luster; David I Bernstein
Journal:  J Occup Environ Med       Date:  2014-04       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.